Keyphrases
Increased Vulnerability
100%
Lysozyme
100%
Streptococcus Pneumoniae
100%
Otitis Media
100%
Middle Ear Infection
15%
S. Pneumoniae
10%
Middle Ear
10%
Muramidase Activity
10%
Therapeutic Agents
5%
Innate Immune Response
5%
Wild Mice
5%
Immunohistochemistry
5%
Adjuvant Therapy
5%
Western Blotting
5%
Ubiquitous Expression
5%
Antimicrobial
5%
Broth
5%
Epithelium
5%
Antimicrobial Activity
5%
Peptidoglycan
5%
Submucosal Glands
5%
Immunolabeling
5%
Quantitative RT-PCR
5%
Immune Molecules
5%
Clinical Grading
5%
Bacterial Cell Wall
5%
Viable Bacteria
5%
Eustachian Tube
5%
Middle Ear Cavity
5%
Radial Diffusion Assay
5%
Immunology and Microbiology
Lysozyme
100%
Streptococcus pneumonia
100%
Otitis Media
100%
Susceptibility
100%
Middle Ear
19%
Pneumococcus
9%
Wild Type Mouse
4%
Infectious Agent
4%
Western Blot
4%
Wild Type
4%
Quantitative Reverse Transcription Polymerase Chain Reaction
4%
Upregulation
4%
Peptidoglycan
4%
Colony Forming Unit S
4%
Colony-Forming Unit
4%
Antimicrobial Activity
4%
Antimicrobial Agent
4%
Immunolabeling
4%
Otitis
4%
Bactericidal Activity
4%
Bacterial Cell Wall
4%
Veterinary Science and Veterinary Medicine
Mouse
100%
Pneumococcus
100%
Middle Ear
100%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Submucosal Glands
25%
Eustachian Tube
25%
Otitis
25%
Immunohistochemistry
25%
Antimicrobial Activity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Streptococcus pneumonia
100%
Otitis Media
100%
Lysozyme
100%
Wild Type Mouse
4%
Western Blot
4%
Infectious Agent
4%
Antiinfective Agent
4%
Antimicrobial Agent
4%
Peptidoglycan
4%
Otitis
4%
Neuroscience
Lysozyme
100%
Streptococcus pneumonia
100%
Western Blot
4%
Immunohistochemistry
4%
Peptidoglycan
4%
Colony Forming Unit S
4%
Antimicrobial Agent
4%
Bacterial Cell Wall
4%